Trial Profile
A Multicenter, Open-Label, Randomized Comparative Study of Tigecycline Vs Ceftriaxone Sodium Plus Metronidazole for the Treatment of Hospitalized Subjects With Complicated Intra-Abdominal Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Feb 2013
Price :
$35
*
At a glance
- Drugs Ceftriaxone (Primary) ; Metronidazole (Primary) ; Tigecycline (Primary)
- Indications Bacterial infections; Intra-abdominal infections
- Focus Therapeutic Use
- Sponsors Pfizer
- 01 Aug 2010 Results have been published in Clinical Microbiology and Infection.
- 16 Jun 2009 Actual patient number (467) added as reported by ClinicalTrials.gov.
- 16 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.